ClinicalTrials.gg
Sign In
Status unknownNCT05677503Updated Jan 12, 2023

Determination of the Red Cell Distribution Width, NT-proBNP and cTnT in Acute Myocardial Infarction Patients

An observational study in Myocardial Infarction, sponsored by Sohag University. Status unknown. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2023-01-12.

Sponsored by Sohag University · Observational

The sponsor has not verified this record recently (last verified Jan 2023), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
30
Ages
18 Years to 80 Years
Sex
All
01

Study summary

the study is to investigate the relationship of several parameters of complete blood count (CBC) including RDW with N-terminal pro-B-type natriuretic peptide (NT-proBNP) and cardiac troponin T (cTnT) in a cohort of acute myocardial infarction (AMI) patients.

Read the detailed description

Patients and methods:

  • Type of study: Observational prospective study
  • Place of study: Sohag cardiology and gastroenterology center, department of cardiology and cardiac care unit.
  • Ethical considerations: This research will be revised by the Scientific Ethical Committee of Sohag University Hospital. Consents will be taken from all patients.

  • Study Methods:

    • A prospective study on 30 patients diagnosed as acute myocardial infarction on which measurement of CBC, serum NT-proBNP, and cTnT levels will be performed at the time of admission and by the time of discharge.

      1. Full history:

        1. Personal history: e.g. age, sex and smoking.
        2. Family history of cardiac diseases
        3. Medical history of: Hypertension, Ischemic heart disease, prior coronary artery bypass grafting, Prior Percutaneous coronary intervention, Prior Stroke, Prior Atrial fibrillation, therapeutic history
      2. Detailed clinical examination
      3. Electrocardiogram

      4. Laboratory investigation:

        1. Routine investigation in the form of CBC including RDW
        2. Specific investigation which include NT-proBNP and cTnT
02

Conditions studied

  • Myocardial Infarction
03

In context

Myocardial Infarction

2,779 studies on the registry are indexed under Myocardial Infarction; 417 are open to participants now.

This study's planned enrollment of 30 is below the median of 500 across 999 observational studies indexed under Myocardial Infarction.

Browse Myocardial Infarction studies →

Lead sponsor

Sohag University is the lead sponsor of 1,220 studies on the registry; 629 are open to participants now.

Browse Sohag University studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

_All patients included in the study will be subjected to:

  1. Full history:

    1. Personal history: e.g. age, sex and smoking.
    2. Family history of cardiac diseases
    3. Medical history of: Hypertension, Ischemic heart disease, prior coronary artery bypass grafting, Prior Percutaneous coronary intervention, Prior Stroke, Prior Atrial fibrillation, therapeutic history
  2. Detailed clinical examination
  3. Electrocardiogram

  4. Laboratory investigation:

    1. Routine investigation in the form of CBC including RDW
    2. Specific investigation which include NT-proBNP and cTnT

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patients diagnosed as acute myocardial infarction

Exclusion criteria

Exclusion Criteria:

Patient with

  • Decompensated heart failure
  • Pulmonary hypertention
  • Acute pulmonary embolism
  • Septic shock
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
30 participants (estimated)
Patient registry
No

Interventions

  • Diagnostic testCBC

    measurement of CBC will be performed at the time of admission and by the time of discharge

  • Diagnostic test(NT-proBNP)

    measurement of serum NT-proBNP levels will be performed at the time of admission and by the time of discharge

  • Diagnostic test(cTnT)

    measurement of cTnT levels will be performed at the time of admission and by the time of discharge

06

What researchers measure

Primary outcomes

  1. complete blood count (CBC)

    measurement of CBC levels will be performed

    Time frame: 7 months

  2. Level of (NT-proBNP)

    measurement of serum NT-proBNP level will be performed

    Time frame: 7 months

  3. Level of (cTnT)

    measurement of cTnT level will be performed

    Time frame: 7 months

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 12, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05677503
Lead sponsor
Sohag University
Responsible party
Hemat Kamel Maarouf (Resident doctor at clinical and chemical pathology department, Sohag University) — Principal investigator
First posted
Jan 10, 2023
Start date
Jan 15, 2023 (estimated)
Primary completion
Jun 30, 2023 (estimated)
Completion
Jul 30, 2023 (estimated)
Last update
Jan 12, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Myocardial Infarction →

Other studies from this sponsor

Sohag University →

Start the discussion